跳至主要内容
临床试验/NCT01128049
NCT01128049已完成不适用

Non-invasive Tear Film Dynamic Measurements in Normal, MGD (Meibomium Gland Dysfunction) and Aqueous Deficient Dry Eye(ADDE) Subjects After Saline Instillation

University of Rochester1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Visual Quality

研究概览

简要总结

Compare the objective tear film dynamic measurements in three different populations (MGD [Meibomium Gland Dysfunction], ADDE [Aqueous Deficient Dry Eye] and normal/control [non-dry eye]) and the subjective experience before and after instilling a single drop of saline in each eye.

Currently available office-based tests for dry eye do not reliably correlate with patients' subjective symptoms. This study is interested in assessing how individuals with these two different ocular surface diseases compare with the normal population when measured objectively using two different instruments.

详细描述

There will be one study day with a single visit that will consist of taking two sets of measurements. Baseline measurements are taken in both eyes using a wavefront sensor to measure visual quality followed by saline instillation. Five minutes after drops, visual quality is again measured to evaluate changes in tear dynamics.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Good general Health
  • The subject must appear able and willing to adhere to the instructions set forth in this protocol (such as not use warm compresses or artificial tears/lubricant or excessive eye makeup before the visit on the study day).

排除标准

  • Ocular disease, infection or inflammation (allergy, blepharitis) that is clinically significant (grade 3 or 4) that in the opinion of the PI would not be a good subject.
  • Systemic disease or use of medication that in the opinion of the PI would not be a good subject.
  • Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
  • Contact lens wearer.
  • Pregnancy or lactation.
  • Diabetes.
  • Inclusion or exclusion criteria of the other cohorts.
  • Cohort Specific Inclusion Criteria:
  • ADDE cohort: Schirmer I < 10 mm, BUT ¬< 5 seconds, Fluorescein 0 or 1, currently using an artificial tear for ocular comfort at least occasionally.
  • MGD cohort: Diagnosis of moderate or severe MGD
  • Normal/Control (Non Dry-Eye): meets general inclusion and exclusion criteria

研究组 & 干预措施

Normal Patient Population

Active Comparator

Non-Dry Eye patient population (intervention remains the same across all arms)

干预措施: Subjective Questionnaire (Behavioral)

Normal Patient Population

Active Comparator

Non-Dry Eye patient population (intervention remains the same across all arms)

干预措施: Measurement with wavefront sensor (right eye, then left eye) (Procedure)

Normal Patient Population

Active Comparator

Non-Dry Eye patient population (intervention remains the same across all arms)

干预措施: Instill Saline Drop (Drug)

MGD Patient Population

Active Comparator

Meibomium Gland Dysfunction population(intervention remains the same across all arms)

干预措施: Subjective Questionnaire (Behavioral)

MGD Patient Population

Active Comparator

Meibomium Gland Dysfunction population(intervention remains the same across all arms)

干预措施: Measurement with wavefront sensor (right eye, then left eye) (Procedure)

MGD Patient Population

Active Comparator

Meibomium Gland Dysfunction population(intervention remains the same across all arms)

干预措施: Instill Saline Drop (Drug)

ADDE Population

Active Comparator

Aqueous Deficient Dry Eye population(intervention remains the same across all arms)

干预措施: Subjective Questionnaire (Behavioral)

ADDE Population

Active Comparator

Aqueous Deficient Dry Eye population(intervention remains the same across all arms)

干预措施: Measurement with wavefront sensor (right eye, then left eye) (Procedure)

ADDE Population

Active Comparator

Aqueous Deficient Dry Eye population(intervention remains the same across all arms)

干预措施: Instill Saline Drop (Drug)

结局指标

主要结局

Visual Quality

时间窗: 5 seconds

Average visual quality change over a 5 second blink cycle caused by movement of the tears over the surface of the eye by measuring optical irregularities.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James V. Aquavella, MD

Medical Doctor and Department Faculty

University of Rochester

研究点 (1)

Loading locations...

相似试验